GERRESHEIMER AG
Commented by Carsten Mainitz on February 12th, 2026 | 07:55 CET
Watch out! Gerresheimer slumps 30%, NEO Battery Materials as a game changer, Schott Pharma surprises positively
Many stories of success and failure are written on the stock market. NEO Battery Materials, the game changer in battery technology, is particularly exciting. The Canadian company offers manufacturers of drones, robots, and electric vehicles customizable high-performance batteries produced in the West. With its innovative approach, the company is setting new standards in terms of performance, charging speed, and price, thereby addressing a huge market that experts estimate will grow to around USD 30 billion by 2032. The examples of Gerresheimer and Schott Pharma show how differently companies in the same industry can develop: Schott exceeded market expectations in the first quarter, while Gerresheimer shocked the markets once again.
Read
Commented by Fabian Lorenz on December 29th, 2025 | 07:00 CET
Comeback 2026! Tenfold potential? Evotec, Gerresheimer, and Desert Gold shares!
Looking for a potential ten-bagger in the gold sector? Analysts believe this could be possible for Desert Gold. The recently published PEA for the flagship gold project is triggering new price speculation. This could finally end the years-long sideways trend and allow the stock to take off. Investors had hoped for a turnaround in 2025 at Evotec. Instead, the biotech stock continued its downward trend. The strategy of the new management team does not appear to have convinced major shareholders either. Gerresheimer was an unpleasant surprise in 2025. At the turn of the year, the Company is at least engaged in damage control. But how significant is the loss of confidence?
Read
Commented by Fabian Lorenz on December 12th, 2025 | 06:55 CET
Buy these stocks now?! Bayer, Gerresheimer, WashTec!
Bayer is undoubtedly one of the positive surprises of 2025 on the German stock market. Operations are running smoothly for the Leverkusen-based company, particularly in the pharmaceutical sector. And next year, the glyphosate disaster could also come to an end. Analysts have now raised their price target. WashTec shares are still at the beginning of an upward trend. Growth, improved margins, a dividend yield of 5%, and a share buyback program continue to argue in favor of buying the stock. Analysts share this opinion. Experts do not yet see the time as right to buy Gerresheimer shares. Although the stock appears to have bottomed out, investors are still advised to wait.
Read
Commented by André Will-Laudien on December 3rd, 2025 | 07:30 CET
Gold, drones, and specialty glass! Just like that, 200% gains out of nowhere with DroneShield, AJN Resources, and Gerresheimer
The stock market is showing its volatile side. While AI, defense, and tech stocks are consolidating, gold and silver are skyrocketing. Sector rotation is therefore in full swing at the end of the year. It is time to take a closer look at some notable movements, because every bull and bear market contains the seeds of the next reversal. DroneShield up 1,000% and then down 75%, AJN Resources suddenly up 200% from a standing start, and Gerresheimer, a fallen angel down 60%, a battered member of the German SME sector. We take a closer look at these stocks – where is it worth taking action?
Read
Commented by André Will-Laudien on November 13th, 2025 | 07:20 CET
Record stock market! And the momentum continues with Palantir, D-Wave, Gerresheimer, and NetraMark
Artificial intelligence (AI) is fundamentally changing drug development by analyzing vast amounts of data in record time and controlling clinical trials more precisely. Advanced systems identify promising drug candidates and predict therapeutic success with impressive accuracy. Companies such as NetraMark are already successfully using these technologies to accelerate development processes. At the same time, the well-known AI stars Palantir and D-Wave are driving the next wave of innovation as pacemakers in data analysis and quantum computing, recording extraordinary share price gains. The German Gerresheimer Group is also increasingly integrating AI-supported solutions into the manufacture of pharmaceutical packaging and medical technology. For investors, this represents a pool of opportunities, but the choice remains difficult!
Read
Commented by Fabian Lorenz on November 12th, 2025 | 06:55 CET
Caution with Plug Power and Gerresheimer! Gold heading toward USD 10,000? What is happening with Formation Metals shares?
Experts see Formation Metals as a potential multi-million-ounce gold story with takeover potential. In addition, the Canadian exploration company's cash position is almost equal to its market capitalization. In contrast, Plug Power's cash burn remains high. Will the stock market be satisfied with the reduction in losses and speculation around AI and energy? And what is Gerresheimer doing? The stock's decline appears to be relentless, with personnel changes having little effect so far. Meanwhile, a drop below the EUR 20 mark is also possible.
Read
Commented by Fabian Lorenz on November 3rd, 2025 | 07:15 CET
SHAKE-UP at Gerresheimer! BUYING OPPORTUNITY at TKMS and Kobo Resources!
Gold and defense stocks continued their recent pause last week, creating potential opportunities. At TKMS, an insider is buying, and analysts see 25% upside potential. Further gains could be on the horizon, as developments in Canada are promising. Kobo Resources continues to impress with its drilling results. Gold discoveries near surface and at depth provide new arguments for a potential takeover. Perhaps as early as next year? A prospective buyer is already mining gold in the neighborhood. Gerresheimer's stock cannot seem to find stability. Then last week came the major shake-up: the CEO is stepping down, and a familiar face is taking over. How will the stock react?
Read
Commented by Carsten Mainitz on October 28th, 2025 | 07:25 CET
Do not miss out! Almonty Industries – Price correction as an opportunity, Gerresheimer and the Damocles Sword of BaFin, TKMS underestimated!
As is well known, there is, of course, no universal rule for stock market success. Successful investors have their own strategies, which often sound very simple at their core. Commodities legend Jim Rogers summed it up with a straightforward formula: investors should simply be aware of supply and demand. Currently, this means that stocks like Almonty Industries rank among the favorites due to the prevailing market conditions. The same applies to defense stocks. But opportunities also exist in stock picking – here, it is worth taking a closer look at the beaten-down Gerresheimer.
Read
Commented by Fabian Lorenz on October 20th, 2025 | 07:00 CEST
BUYING OPPORTUNITY!? Gerresheimer crash! RENK correction! Nakiki shares following in the Bitcoin footsteps of Strategy and Metaplanet!
Nakiki SE is increasingly electrifying stock investors and the Bitcoin community. Following in the footsteps of Strategy, the Company aims to become the first German Bitcoin Treasury company in the regulated market. Around the initial Bitcoin purchases, Metaplanet and Capital B achieved price gains of over 100%. Could Nakiki follow suit? RENK shares are currently undergoing a correction. One analyst recently pointed out issues in the US business. Thursday could be an exciting day for RENK shareholders. Is it worth entering now? As for Gerresheimer, the stock appears unable to find a bottom. Analysts are far too slow in adjusting their price targets.
Read
Commented by Fabian Lorenz on October 15th, 2025 | 08:35 CEST
BUYING OPPORTUNITY or Sell? Plug Power, Gerresheimer, AI insider tip NetraMark!
The stock markets are using the tariff dispute between the US and China as a reason for a correction. As a result, AI insider tip NetraMark has lost around 30% of its value in recent weeks. However, there is positive company news, and pressure from the US government on the biotech and pharmaceutical industry should generate additional interest in NetraMark's technology. So, is the correction a buying opportunity? And what about Plug Power? After the spectacular rise in the share price, the first analyst is already sounding a warning. Losses, and thus financing requirements, are likely to remain high. Gerresheimer's price targets are currently tumbling. Unfortunately, however, analysts are only just catching up with the stock's decline. Buy now or even sell?
Read